The new regulation of non-medical neurotechnologies in the European Union: overview and reflection
Files
Publication date
2024-07-01
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by_nc_nd
Abstract
The regulation of neurotechnologies for non-medical purposes such as enhancement, gaming, or well-being is a topic of ongoing controversy. Without much attention, the European Union addressed it by two implementing regulations to the Medical Device Regulation (MDR) for noninvasive brain stimulation devices, passed in December 2022. This paper presents main aspect of these regulations and the conditions for placing non-medical neurodevices on the EU market, especially the risk threshold and the requirement for pre-market certification. It also provides a first critical comment on selected aspects and the unclear situation regarding research only devices which has alarmed the European neurotechnology sector.
Keywords
enhancement, Medical Device Regulation, neuroscience, research and development, risk assessment, technology governance, Medicine (miscellaneous), Biochemistry, Genetics and Molecular Biology (miscellaneous), Law
Citation
Bublitz, C & Ligthart, S 2024, 'The new regulation of non-medical neurotechnologies in the European Union : overview and reflection', Journal of Law and the Biosciences, vol. 11, no. 2. https://doi.org/10.1093/jlb/lsae021